Upfront autologous stem cell transplantation (ASCT) versus carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation with K maintenance in transplant-eligible, newly diagnosed (NDTE) multiple myeloma (MM)
Yong, Kwee, Camilleri, Marquita, Wilson, William, Ramasamy, Karthink, Streetly, Matthew J., Sive, Jonathan, Bygrave, Ceri, Chapman, Michael A, De Tute, Ruth, Chavda, Selina J, Phillips, Elizabeth, Cuadrado, Maria, Pang, Gavin, Jenner, Richard, Dadaga, Tushhar, Kamora, Sumaiya, Cavenagh, James D., Clifton-Hadley, Laura, Owen, Roger G., Popat, Rakesh
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article